Cardiogen
Heart muscle bioregulator peptide from the Khavinson series. Short peptide (2-4 amino acids) that targets specific tissue for gene expression regulation and organ health optimization.
Research Status
Limited Clinical Data
For research purposes only. Not approved for human use. Not medical advice.
Research Areas
Side Effects
Mild redness, swelling, or itching at the injection site may occur. Usually resolves within 1-2 hours. Rotate injection sites to minimize recurrence. Apply ice if needed.
Occasional headache reported in early use. Typically resolves within 24-48 hours. Ensure adequate hydration and consider taking the injection in the evening if morning dosing causes discomfort.
Rare reports of transient dizziness. Sit or lie down if this occurs. Ensure you are well-hydrated and have eaten a light meal before injection.
Rare but serious risk with any peptide. Signs include rash, difficulty breathing, swelling of face or throat, or severe itching. Seek immediate medical attention if these symptoms occur. Discontinue use and inform your healthcare provider.
Repeated injections at the same site may cause localized fat loss or thickening. Prevent by rotating injection sites systematically. Do not inject into the same site more than once per week.
Dosing Reference
| Parameter | Value |
|---|---|
| Dose range | 10-20 mcg |
| Frequency | 1x daily |
| Timing | Morning, subcutaneous or sublingual |
| Route | Subcutaneous |
Khavinson bioregulator peptide. Limited Western clinical trials; primarily studied in Russian and Eastern European populations. Start at lower end (10 mcg) and assess tolerance. For research purposes only.
Research disclaimer
Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.
Reconstitution Guide
Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution
Do not shake the vial vigorously; gentle swirling prevents peptide degradation
Discard immediately if the solution appears cloudy, discolored, or contains visible particles
Use within 30 days of reconstitution when stored at 2–8°C
Do not freeze the reconstituted solution; freezing may denature the peptide
Use the PeptideVolt reconstitution calculator for your exact concentration
Molecular and Pharmacological Data
Cardiogen is a short-chain peptide bioregulator that is hypothesized to regulate gene expression specifically in cardiac muscle tissue through tissue-selective signaling pathways. The peptide is proposed to enhance myocardial energy metabolism, support cardiomyocyte survival and regeneration, and promote healthy vascular endothelial function. The exact molecular mechanism remains incompletely characterized in Western literature, though Russian research suggests it may modulate growth factors and metabolic pathways critical to cardiac homeostasis.
Tissue-Selective Gene Expression
Khavinson bioregulators are proposed to act as signaling molecules that preferentially target cardiac tissue and regulate the expression of genes involved in myocardial contractility, energy production, and cellular repair.
Myocardial Energy Metabolism
The peptide may enhance ATP production and mitochondrial function in cardiomyocytes, supporting sustained contractile force and exercise tolerance.
Vascular Endothelial Function
Cardiogen may promote nitric oxide production and endothelial health, supporting healthy blood pressure regulation and coronary blood flow.
Cardioprotection and Regeneration
The peptide may activate survival pathways in cardiomyocytes and support tissue repair mechanisms following cardiac stress or aging.
- Cardiogen is a member of the Khavinson peptide bioregulator family, which are short peptides (2-4 amino acids) derived from animal tissues
- The peptide is proposed to work through tissue-selective mechanisms rather than systemic hormone-like signaling
- Most clinical evidence comes from Russian and Eastern European research; Western clinical trials are limited
- The exact amino acid sequence and detailed molecular mechanism have not been widely published in peer-reviewed English-language literature
- Bioregulator peptides are hypothesized to restore age-related declines in tissue-specific gene expression
Track your Cardiogen research
Free account. No credit card required.
Browse the Research Library
40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.
View all peptidesResearch Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Cardiogen is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.